|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,951.00 INR | +0.57% |
|
-1.95% | +13.45% |
| 08-05 | CRISIL Keeps AAA Rating on Sun Pharmaceutical's Bank Facilities | MT |
| 07-31 | Sun Pharmaceutical Industries Limited, Q1 2027 Earnings Call, Jul 31, 2026 |
| Market Cap | 4,681B 49.14B 42.64B 39.93B 36.53B 68.96B 69.86B 467B 183B 2,339B 185B 180B 7,785B | P/E 2027 * |
35.9x | P/E 2028 * | 29.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4,402B 46.21B 40.1B 37.55B 34.35B 64.85B 65.69B 439B 172B 2,199B 174B 170B 7,321B | EV / Sales 2027 * |
6.76x | EV / Sales 2028 * | 5.8x |
| Free-Float |
44.39% | Yield 2027 * |
0.88% | Yield 2028 * | 1.02% |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | +0.57% | ||
| 1 week | -1.95% | ||
| Current month | -1.98% | ||
| 1 month | +2.43% | ||
| 3 months | +7.15% | ||
| 6 months | +14.59% | ||
| Current year | +13.45% |
| 1 week | 1,930 |  | 2,046.9 |
| 1 month | 1,875.1 | | 2,046.9 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,548 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 01/09/2025 | |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 73 | 25/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | -1.95% | +19.54% | +71.30% | 48.95B | |
| +3.09% | +5.78% | +64.08% | +134.31% | 39.36B | |
| +1.25% | +0.18% | -1.52% | +22.09% | 12.39B | |
| -1.17% | -1.31% | +15.39% | +70.53% | 11.76B | |
| +1.53% | -0.38% | +30.75% | +134.53% | 9.14B | |
| -0.25% | +2.90% | +18.08% | +33.63% | 7.05B | |
| +1.61% | -6.16% | +38.63% | -12.74% | 6.86B | |
| +0.49% | +0.37% | +10.59% | +182.50% | 6.7B | |
| -1.46% | +2.33% | -30.59% | +14.13% | 5.67B | |
| +0.96% | +2.18% | +31.66% | +98.65% | 4.51B | |
| Average | +0.66% | -0.30% | +19.66% | +74.89% | 15.24B | |
| Weighted average by Cap. | +1.14% | -0.35% | +28.57% | +85.35% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 651B 6.84B 5.93B 5.55B 5.08B 9.59B 9.72B 64.98B 25.5B 325B 25.67B 25.11B 1,083B | 747B 7.84B 6.81B 6.37B 5.83B 11.01B 11.15B 74.57B 29.26B 373B 29.45B 28.81B 1,243B |
| Net income | 131B 1.37B 1.19B 1.11B 1.02B 1.92B 1.95B 13.02B 5.11B 65.2B 5.14B 5.03B 217B | 158B 1.66B 1.44B 1.35B 1.23B 2.33B 2.36B 15.75B 6.18B 78.86B 6.22B 6.09B 262B |
| Net Debt | -279B -2.93B -2.54B -2.38B -2.18B -4.11B -4.16B -27.85B -10.93B -139B -11B -10.76B -464B | -349B -3.67B -3.18B -2.98B -2.72B -5.14B -5.21B -34.85B -13.68B -174B -13.76B -13.46B -581B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | ₹1,951.00 | +0.57% | 1,864,891 |
| 05/08/26 | ₹1,940.00 | -1.22% | 2,152,829 |
| 04/08/26 | ₹1,964.00 | +0.03% | 1,452,888 |
| 03/08/26 | ₹1,963.50 | -1.36% | 3,972,351 |
| 31/07/26 | ₹1,990.50 | -0.53% | 4,954,449 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
